Myricetin, found in honey, vegetables, and wine, has a regressive effect on steatosis development in preclinical NASH models by promoting NRF2-mediated mitochondrial functionality, thereby increasing antioxidative enzyme activities and peroxisome proliferator-activated receptor (PPAR)-mediated fat decomposition [11]. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.